- Home
- SHCO vs MNKD Comparison
SHCO vs MNKD Comparison
Compare SHCO & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHCO
- MNKD
- Stock Information
- Founded
- SHCO 1995
- MNKD 1991
- Country
- SHCO United States
- MNKD United States
- Employees
- SHCO N/A
- MNKD N/A
- Industry
- SHCO Hotels/Resorts
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- SHCO Consumer Discretionary
- MNKD Health Care
- Exchange
- SHCO Nasdaq
- MNKD Nasdaq
- Market Cap
- SHCO 1.2B
- MNKD 1.6B
- IPO Year
- SHCO 2021
- MNKD 2004
- Fundamental
- Price
- SHCO $5.19
- MNKD $5.15
- Analyst Decision
- SHCO Strong Buy
- MNKD Buy
- Analyst Count
- SHCO 3
- MNKD 6
- Target Price
- SHCO $7.00
- MNKD $8.92
- AVG Volume (30 Days)
- SHCO 369.4K
- MNKD 2.3M
- Earning Date
- SHCO 05-09-2025
- MNKD 05-07-2025
- Dividend Yield
- SHCO N/A
- MNKD N/A
- EPS Growth
- SHCO N/A
- MNKD N/A
- EPS
- SHCO N/A
- MNKD 0.10
- Revenue
- SHCO $1,198,989,000.00
- MNKD $285,504,000.00
- Revenue This Year
- SHCO $9.52
- MNKD $14.66
- Revenue Next Year
- SHCO $7.40
- MNKD $14.27
- P/E Ratio
- SHCO N/A
- MNKD $51.40
- Revenue Growth
- SHCO 8.45
- MNKD 43.50
- 52 Week Low
- SHCO $4.43
- MNKD $3.97
- 52 Week High
- SHCO $8.47
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- SHCO 16.57
- MNKD 39.69
- Support Level
- SHCO $6.20
- MNKD $4.77
- Resistance Level
- SHCO $6.70
- MNKD $5.74
- Average True Range (ATR)
- SHCO 0.34
- MNKD 0.25
- MACD
- SHCO -0.21
- MNKD 0.01
- Stochastic Oscillator
- SHCO 1.40
- MNKD 35.51
About SHCO Soho House & Co Inc.
Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create and flourish all over the world. It offers lease agreement Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are; United Kingdom, North America, and Europe and Rest of the World. Majority of its revenue is generated from the North America segment which encompasses its operating units in North America, including; Soho Houses, stand-alone U.S. restaurants and the Willows Inn in Palm Springs, Soho Friends, and the management fees from Soho Beach House Canouan.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.